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Abstract L-Asparaginase (E.C. 3.5.1.1) is used as a ther-
apeutic agent in the treatment of acute childhood lympho-
blastic leukemia. It is found in a variety of organisms such
as microbes, plants and mammals. In plants, L-asparaginase
enzymes are required to catalyze the release of ammonia
from asparagine, which is the main nitrogen-relocation
molecule in these organisms. An Indian medicinal plant,
Withania somnifera was reported as a novel source of
L-asparaginase. L-Asparaginase from W. somnifera was
cloned and overexpressed in E. coli. The enzymatic prop-
erties of the recombinant enzyme were investigated and the
kinetic parameters (Km, kcat) for a number of substrates were
determined. The kinetic parameters of selected substrates
were determined at various pH and the pH- and tempera-
ture-dependence profiles were analyzed. WA gene suc-
cessfully cloned into E. coli BL21 (DE3) showed high
asparaginase activity with a specific activity of 17.3 IU/mg
protein.
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Abbreviations
WA Withania somnifera L-asparaginase
WsA Recombinant L-asparaginase
Tas1 Threonine aspartase (taspase1)
PDB Protein Data Bank
LB Luria broth
Introduction
The interest in L-asparaginases arose due to their antitumor
activity. Unlike normal cells, malignant cells can only
slowly synthesize L-asn and are dependent on an exogenous
supply (Lee et al. 1989). In contrast, normal cells are
protected from Asn-starvation due to their ability to pro-
duce this amino acid (Duval et al. 2002). The antineo-
plastic activity results from depletion of the circulating
pools of L-asn by L-asparaginase (Lee et al. 1989). The
L-asparaginases of Erwinia and E. coli have been employed
for many years as effective drugs in the treatment of acute
lymphoblastic leukemia and leukemia lymphosarcoma
(Kristiansen et al. 1970; Kozak et al. 2002; Graham 2003),
but their therapeutic response rarely occurs without some
evidence of toxicity (Duval et al. 2002). Their main side
effects are anaphylaxis, pancreatitis, diabetes, leucopoenia,
neurological seizures and coagulation abnormalities that
may lead to intracranial thrombosis or hemorrhage (Duval
et al. 2002). Because the L-asparaginases from E. coli and
Erwinia possess different immunological specificities, they
offer an important alternative therapy if a patient becomes
hypersensitive to one of the enzymes (Lee et al. 1989).
In comparison to the bacterial enzymes, the plant
enzymes have been studied less thoroughly. In plants,
L-asparagine is the major nitrogen storage and transport
compound and it may also accumulate under stress con-
ditions (Bruneau et al. 2006). There are two groups of such
proteins, called potassium-dependent and potassium-inde-
pendent asparaginases (Sodek et al. 1980; Sieciechowicz
et al. 1988). Both enzyme groups have significant levels of
sequence similarity. The plant asparaginase amino acid
sequences did not have any significant similarity with
microbial asparaginase but was 23% identical and 66%
similar to a human glycosylasparaginase (Lough et al. 1992).
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The crystal structure of plant L-asparaginase showed sig-
nificant similarity with bacterial as well as threonine
aspartase (Karolina et al. 2006).
Withania somnifera (L.) Dunal was considered a rasa-
yana herb, which works on a non-specific basis to increase
health and longevity. The species name somnifera means
‘‘sleep-making’’ in Latin, indicating to its sedating prop-
erties. Extracts of the fruits, leaves and seeds of W. som-
nifera L. were traditionally used in the Ayurvedic system
as aphrodisiacs, diuretics and for treating memory loss.
W. somnifera L. was reported as a potential source for
L-asparaginase (Oza et al. 2009) and the purified enzyme
was shown to have anti-tumor activity on cell cultures (Oza
et al. 2010).
The toxicity is partially attributable to the glutaminase
activity of these enzymes (Howard and Carpenter 1972).
L-asparaginases with high specificity for L-asparagine and
negligible activity against L-glutamine are reported to be
less troublesome during the course of anti-cancer therapy
(Hawkins et al. 2004). The interest in L-asparaginase from
W. somnifera L. arose from the fact that it has less toxicity
compared to bacterial L-asparaginase (Oza et al. 2010).
Despite the therapeutic potential of WA, this enzyme is
less characterized, compared to other L-asparaginases.
Detailed studies of protein and large scale production of the
therapeutic protein through recombinant enzyme have not
been reported so far from W. somnifera L. Therefore, in
this study expression, purification and characterization of
recombinant L-asparaginase from W. somnifera is reported
for the first time.
Materials and methods
Materials
All degenerate oligonucleotides and L-asparaginase-specific
primers used in this study were synthesized by MWG
(India). Oligo (dT)-anchor primer and all other chemicals
such as M-MuLV reverse transcriptase, DTT, RNase
inhibitor and many more for amplification of cDNA were
obtained from Bangalore Genei (India). Taq DNA poly-
merase and MgCl2 were from Sigma-Aldrich Co (USA).
Restriction enzyme HindIII and XholI was obtained from
NEB (UK). Qiagen Plasmid Maxi Kit and transformation
chemicals were from Qiagen (Germany). L-Asparagine was
obtained from Sigma-Aldrich Co.
Withania somnifera (L.) Dunal was collected from the
Botanical garden, Department of Biosciences, Sardar Patel
University, Vallabh Vidyanagar, Gujarat (India). A voucher
specimen of the plant was submitted to the department her-
barium. Identification of the plant was confirmed through
comparison with a herbarium specimen number 10337.
RNA isolation and cDNA synthesis
One gram of immature, 10-day-old fruits was washed
thoroughly with tap water followed by sterile distilled
water to remove extraneous material and homogenized in
liquid nitrogen using a homogenizer. Extraction of total
RNA was carried out using TRI reagent (Sigma).
Sequences homologous to WA were sought in the NCBI
using BLAST. A cDNA sequence of L-asparaginase from
A. thaliana (GenBank accession no: Z34884) was used for
cDNA synthesis. Reverse transcriptase PCR was used to
amplify the full-length cDNA. 1 U of DNase was added
into total RNA sample (5 lg), mixed properly and incu-
bated for 15 min at room temperature. DNase was inacti-
vated by incubation at 75 C for 10 min and it was carried
out before RT-PCR. The cDNA synthesis was carried out
in a total volume of 20 ll, containing 100 ng of total RNA,
100 pmol of random hexamer, DEPC treated water, RNase
inhibitor, DTT, RT Buffer, dNTP mix and M-MuLV
reverse transcriptase. cDNA was amplified through PCR
using the heterologous primers synthesized to the 50-region
of the cDNA (50-ATG GGC GGC TGG AGC ATT GC-30)
and to the 30-end of the cDNA (50-CTT TCA GGC TCA
GGC CTT TA-30), 100 pmol of both primer, 100 ng
cDNA, 0.2 mM of each dNTP, 5 ll 109 Taq buffer and
2 units of Taq DNA polymerase (Bangalore Genei). The
PCR procedure comprised 35 cycles of 1.0 min at 95 C,
1.0 min at 54 C and 1.0 min at 72 C. A final extension
time at 72 C for 5 min was performed after the 35 cycles.
The resulting PCR amplicon was sequenced in multicol-
umn sequencer (ABI, USA). The sequence was validated
by BLASTn and submitted to NCBI.
Cloning and overexpression of WsA
For sticky end ligation, the primers were modified in such a
manner that they included the RE sites at both end of the
PCR amplicon. The following primers were used WSF:
50-GGC TTC TTA CTC GAG AAT GGG CGG CTG GAG
CAT TGC-30 (XholI site is underlined) and the reverse
primer WSR: 50-GGC TTC TTA AAG CTT CTT TCA
GGC TCA GGC CTT TA-30 (HindIII site is underlined).
The resulting PCR amplicon which was obtained through
RTPCR was re-amplified with the modified primers with
the same condition as above. The modified amplified
product and plasmid expression vector pRSET A (Invit-
rogen USA) were digested with HindIII and XholI (NEB,
USA). The digested PCR product and plasmid vector were
run on agarose electrophoresis and purified from the gel.
The purified product was ligated into pRSET A using T4
ligase enzyme. The resulting expression construct pRSET
A was used to transform competent DH5a E. coli cells. The
transformed E. coli cells, harboring plasmid pRSET A,
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were grown at 37 C in 100 ml LB medium containing
100 lg/ml ampicillin. The plasmid was isolated from
DH5a E. coli and used to transform competent BL21 (DE3)
E. coli. The cells were grown into LB agar plate containing
ampicillin and X-gal. The recombinant clones were iden-
tified by blue/white selection and grown at 37 C in 500 ml
LB medium containing 100 lg/ml ampicillin. Synthesis of
WsA was induced by the addition of 1 mM IPTG when the
absorbance at 600 nm was 0.6–0.8 (Sambrook et al. 1989).
Purification of WsA
Five hours after induction by IPTG, cells were harvested by
centrifugation at 10,000g and 4 C for 20 min. Cells
obtained from culture (about 2 g of wet weight) were
resuspended in 5 ml potassium phosphate buffer (10 mM,
pH 6.5), sonicated and centrifuged at 14,000g for 30 min at
4 C. The supernatant was collected and used for purifi-
cation. The GeNeiTM His-Tag fusion protein purification
kit containing Nickel CL-Agarose column (2.5 9 10.0 cm)
was used for the purification of WsA. The fractions col-
lected (1 ml) were assayed for asparaginase activity by
Nessler’s reagent method (Wriston and Yellin 1973) and
protein (A280) estimation (Lowry et al. 1951). The purified
enzyme was dialyzed to remove salt.
Kinetic analysis
Steady-state kinetic measurements were performed in
10 mM potassium phosphate buffer pH 6.5 at 37 C, by
varying the concentration of the substrate L-asn. The
kinetic parameters kcat, Km and Vmax were calculated by
non-linear regression analysis of experimental steady-state
data. Kinetic data kcat and Km were calculated using the
GraFit program (Erithacus Software Ltd.).
pH and temperature effect on activity
The pH profile of WsA was studied using the following
buffers, all at 0.05 M final concentration at 37 C with
different buffers: 0.01 M sodium acetate (pH 4.0–5.5),
0.01 M Na2HPo4/NaH2Po4 (pH 6.0–7.0) and 0.01 M
sodium borate buffer (pH 7.5–9.0), in a range of 4.0–9.0
and data were analyzed through statistical software. The
dependence of the reaction rate on temperature was
evaluated by measuring enzyme activity for L-asn, at dif-
ferent temperature values under the same conditions
reported above. The data were analyzed by the SPSS
software.
Results
cDNA synthesis by reverse transcription
The total RNA yield obtained through TRI method from W.
somnifera L. was of good quality and suitable for further
use. The DNase-treated RNA was used as a template for
cDNA synthesis. The cDNA for L-asparaginase obtained
was amplified by PCR. The PCR product obtained was a
single band of around 850 bp in agarose gel electropho-
resis. The PCR amplicon was sequenced using both for-
ward and reverse primers in a multicolumn sequencer
(ABI). The sequence was validated with BLAST and
submitted to gene bank (FJ645259).
Cloning and overexpression of WsA
To select the required expression product, prSET-A vector
was chosen. The amplified product and prSET-A were
digested with HindIII and XholI, respectively, and the
digested PCR amplicon was cloned into the T7 expression
vector pRSET A. The fusion product was named pr/WsA.
The pr/WsA plasmid was used to initially transform into
E. coli DH5a. The plasmid from DH5a E. coli cells was
purified and used to transform expression host E. coli BL21
(DE3). Cell-free extract of the E. coli BL21 (DE3) showed
high asparaginase activity with a specific activity of
17.3 IU/mg protein.
Purification of WsA
WsA was purified in a one-step procedure (Table 1). In the
purification scheme, a His-Tag fusion protein purification
Nickel CL-Agarose column was employed. Non-pre-trea-
ted enzyme extract was applied directly to the Nickel
CL-Agarose column equilibrated with 10 mM potassium
phosphate buffer pH 7.5. The enzyme was adsorbed at
pH 6.5 and eluted specifically by breaking the His-Tag.
The purity of the final WsA preparation was evaluated by
Table 1 Purification of recombinant L-asparaginase from E. coli
Sample Volume (ml) Protein (mg) Activity (IU) Specific activity (IU/mg) Fold purification Recovery (%)
Cell-free extract 5.0 12.3 212.0 17.3 1.0 100
Nickel CL-agarose 1.0 1.7 95.0 55.8 3.22 44.8
One international unit (IU) of L-asparaginase is that amount of enzyme which liberates 1 lmol of ammonia in 1 min at 37 C
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SDS-PAGE, which showed the presence of a single poly-
peptide chain (Fig. 1).
Kinetic analysis
The kinetic properties of the WsA were investigated. The
kcat and Km parameters for substrate were determined by
steady-state kinetic analysis (Table 2). The Km values for
the recombinant L-asparaginase with L-asparagine and
L-glutamine were determined as 0.075 and 4.5 mM,
respectively. The catalytic constant kcat of WsA is signifi-
cantly higher than that of the recombinant L-asparaginase
from E. coli (Km; 0.085 and 0.058 mM and kcat; -31.4 and
23.8 9 103 s-1) (Kotzia and Labrou 2005, 2007). The
glutaminase activity was responsible for side effects during
treatment (Hawkins et al. 2004). The purified enzyme
showed very low glutaminase activity, which is about 2%
of that of L-asparaginase activity. The activity was signif-
icantly lower than that exhibited by the E. coli and Erwinia
chrysanthemi enzymes (Howard and Carpenter 1972).
Effect of temperature and pH on enzyme activity
The optimum pH for WsA enzyme was found to be 8.0
(Fig. 2a) similar to that of E. coli and the wild-type enzyme
which also had pH optima around 8.5 (Oza et al. 2009).
The temperature optimum (37 C) of the enzyme (Fig. 2b)
is also similar to all other reported bacterial sources which
are already being used in the treatment of leukemia.
Discussion
The role of L-asparaginase has been studied for the past
30 years. It plays a unique role in the treatment of acute
lymphoblastic leukemia. The production of plant L-aspar-
aginase in large quantities was quite difficult compared to
microorganisms. Currently, L-asparaginase for the treat-
ment of ALL is produced from microorganisms. A major
drawback of using microorganisms as a source of this drug
is a number of adverse effects of the enzyme. As a viable
alternative to bacterial L-asp we selected a plant gene as a
source to overcome the limitations of the bacterial enzyme.
It is evident from the results that the L-asparaginase gene of
WA has successfully been cloned and expressed at a high
level in E. coli. The purified enzyme showed a high level of
activity at 95 IU/ml. L-Asparaginase production by E. coli
and E. chrysanthemi has been studied previously. How-
ever, research on molecular cloning and gene expression of
L-asparaginase from plants has scarcely been reported.
Gilbert et al. (1986) and Liu et al. (1996) have cloned and
expressed E. coli and E. chrysanthemi L-asparaginase gene
into E. coli. The enzyme activities of these recombinant
strains were 49 and 106 IU/ml, respectively. In the present
study, lac and tac promoters were used along with IPTG,
for the induction of the enzyme. The recombinant strain
produced up to eightfold higher activity as compared to the
wild-type E. coli; hence, the recombinant strain is suitable
for the production of L-asparaginase. The purification of
L-asparaginase could be achieved relatively easily due to a
His-Tag in the recombinant protein. The protein was
purified with the help of affinity chromatography.
Fig. 1 SDS-polyacrylamide gel electrophoresis of L-asparaginase
preparations. Protein bands were stained with colloidal stain. Lane A
Molecular weight markers. Lane B WsA crude preparation after
induction with 1 mM IPTG. Lane C Purified WsA sample
Table 2 Kinetic parameters of WsA and WA
Enzyme Substrate Km (mM) kcat (s
-1) kcat/Km (M
-1 s-1) (9103)
WA L-asn 0.06 ± 0.02 17.8 ± 0.1 (9103) 296.6
L-glu 5.4 ± 0.4 191 ± 3.0 35.4
WsA L-asn 0.07 ± 0.02 28.6 ± 0.1 (9103) 408.6
L-glu 4.2 ± 0.3 343 ± 5.0 81.3
Steady-state kinetic measurements were performed at 37 C. All initial velocities were determined in triplicate. The kinetic parameters kcat and
Km were calculated using the GraFit program (Erithacus Software Ltd.)
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A comparison of the enzyme characters of recombinant
W. somnifera and that of E. coli and E. carotovora indicate
that the WsA enzyme is superior in many parameters.
While the optimum temperature and pH for the enzyme
activity were similar, the L-glutaminase activity was much
lower. A major reason for the undesirable side effects of
the bacterial enzyme is their glutaminase activity (Howard
and Carpenter 1972). Moreover, the enzyme turnover rate
of the WsA enzyme was much higher than the bacterial
enzyme. The constant kcat of WsA is higher than that of
L-asparaginase from E. coli (Kotzia and Labrou 2005, 2007).
The purified enzyme exhibited very low L-glutaminase
activity, which is about 2% of that of L-asparaginase
activity which is significantly lower than that exhibited by
the E. coli and E. chrysanthemi enzymes (Narta et al.
2007). The Km value of WsA indicates that the enzyme
efficiency is similar to the wild-type enzyme (Oza et al.
2009). The optimum pH and temperature of WsA were
similar to other reported sources such as E. coli and wild-
type W. somnifera L. (Gilbert et al. 1986; Oza et al. 2009).
In conclusion, in the present study, a new L-asparaginase
from W. somnifera L. has been successfully cloned,
expressed and characterized. The results of the present
work form the basis for a rational and combinatorial design
of new engineered forms of WsA with improved specificity
and enhanced catalytic efficiency toward L-asn for future
therapeutic use.
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